文献速递心脑血管急症创伤与烧伤

服用直接口服抗凝药的成人轻度颅脑损伤后发生显著创伤性脑损伤的风险:队列研究与更新荟萃分析

Risk of significant traumatic brain injury in adults with minor head injury taking direct oral anticoagulants: a cohort study and updated meta-analysis.
PubMed 文献 · Emerg Med J · 2020-09-08
一句话结论服用DOAC的成人轻度颅脑损伤后30天内不良结局风险约3.4%,作者认为该风险较低,支持医患共同决策而非常规影像检查。

英国南约克郡主要创伤中心于2018年6月26日至9月3日开展观察性队列研究,前瞻性纳入148例服用DOAC的成人轻度颅脑损伤患者(GCS 15分107例,72%;GCS 14分41例,28%),中位年龄82岁,96%为平地跌倒。主要终点为30天内不良结局(神经外科手术、颅内出血或颅脑损伤死亡),发生率为3.4%(5/148,95%CI 1.4%至8.0%);5例颅内出血中1例30天内死亡,1例接受凝血酶原复合物治疗,无患者接受重症监护管理或神经外科干预。更新随机效应荟萃分析纳入本研究和另外两项近期研究,加权总体不良结局风险为3.2%(29/787,95%CI 2.0%至4.4%)。作者结论认为服用DOAC者轻度颅脑损伤后不良结局风险似乎较低,这些发现支持医患共同决策而非常规影像检查。

要点

  • 服用DOAC的成人轻度颅脑损伤患者30天内不良结局(神经外科手术、颅内出血或颅脑损伤死亡)风险为3.4%(5/148,95%CI 1.4%至8.0%)。
  • 更新随机效应荟萃分析(含本研究和另外两项近期研究)显示加权总体不良结局风险为3.2%(29/787,95%CI 2.0%至4.4%)。
  • 148例中5例发生颅内出血,其中1例30天内死亡;1例接受凝血酶原复合物治疗,无患者接受重症监护管理或神经外科干预。
  • 作者结论认为服用DOAC者轻度颅脑损伤后不良结局风险似乎较低,这些发现支持医患共同决策而非常规影像检查。

适用人群与场景

  • 英国南约克郡主要创伤中心于2018年6月26日至9月3日前瞻性识别的服用DOAC的成人轻度颅脑损伤患者,共148例。
  • 患者中位年龄82岁,96%(142/148)为平地跌倒受伤;GCS 15分107例(72%),GCS 14分41例(28%)。

研究设计与关键结果

  • 研究类型为观察性队列研究,行于英国南约克郡主要创伤中心,2018年6月26日至9月3日前瞻性识别服用DOAC的成人轻度颅脑损伤患者,病例确认辅以放射科和急诊信息技术系统筛查,共纳入148例。
  • 主要终点为30天内不良结局(神经外科手术、颅内出血或颅脑损伤死亡),发生率为3.4%(5/148,95%CI 1.4%至8.0%)。
  • 5例发生颅内出血,其中1例30天内死亡;1例接受凝血酶原复合物治疗;无患者接受重症监护管理或神经外科干预。
  • 更新随机效应荟萃分析纳入本研究和另外两项近期研究,加权总体不良结局风险为3.2%(29/787,95%CI 2.0%至4.4%)。

证据类型、等级与局限

  • 证据类型为观察性队列研究及更新随机效应荟萃分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为服用DOAC者轻度颅脑损伤后不良结局风险似乎较低,这些发现支持医患共同决策而非常规影像检查。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients taking direct oral anticoagulants (DOACs) commonly undergo CT head imaging after minor head injury, regardless of symptoms or signs. However, the risk of intracranial haemorrhage (ICH) in such patients is unclear, and further research has been recommended by the UK National Institute for Health and Care Excellence head injury guideline group.

METHODS: An observational cohort study was performed in the UK South Yorkshire major trauma centre between 26 June and 3 September 2018. Adult patients taking DOACs with minor head injury were prospectively identified, with case ascertainment supplemented by screening of radiology and ED information technology systems. Clinical and outcome data were subsequently collated from patient records. The primary endpoint was adverse outcome within 30 days, comprising: neurosurgery, ICH or death due to head injury. A previously published meta-analysis was updated with the current results and the findings of other recent studies.

RESULTS: 148 patients with minor head injury were included (GCS 15, n=107, 72%; GCS 14, n=41, 28%). Patients were elderly (median 82 years) and most frequently injured from ground level falls (n=142, 96%). Overall risk of adverse outcome was 3.4% (5/148, 95% CI 1.4% to 8.0%). Five patients had ICH, of whom one died within 30 days. One patient was treated with prothrombin complex concentrate but no patient received critical care management or underwent neurosurgical intervention. Updated random effects meta-analysis, including the current results and two further recent studies, showed a weighted overall risk of adverse outcome of 3.2% (n=29/787, 95% CI 2.0% to 4.4%).

CONCLUSIONS: The risk of adverse outcome following mild head injury in patients taking DOACs appears low. These findings would support shared patient-clinician decision making, rather than routine imaging, following minor head injury while taking DOACs.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Fuller G, Sabir L, Evans R, et al. Risk of significant traumatic brain injury in adults with minor head injury taking direct oral anticoagulants: a cohort study and updated meta-analysis. Emerg Med J. 2020. PMID: 32900858. doi:10.1136/emermed-2019-209307

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。